Nanotechnology at the Molecular Level

Abstract

Materials with external dimensions of one or more nanometers are referred to as nanomaterials. These structures result from a number of manufacturing processes. They are used in many industries, including pharmaceuticals, which is the most significant one. Numerous variables, including size, shape, surface morphology, crystallinity, solubility, etc., affect physical properties. While new physical and chemical processes are being created constantly, the biological method is the ideal strategy for synthesizing nanoparticles since it is straightforward, safe, and economical. Different kinds of nanoparticles can be metabolically synthesized by a wide variety of biological sources, including plants, bacteria, fungi, and yeast. There are many biomolecules, including proteins and coenzymes, that can change the metal salts into the necessary nanoparticles. There were numerous techniques for creating RNA nanoparticles. The first tactic makes use of the natural RNA nanoparticles' collection process. The second strategy entails extending the widely used DNA nanotechnology approach to the field of RNA; the third strategy uses computational methods to produce RNA nanoparticles; and the fourth strategy uses preexisting RNA structures or those with known properties as fundamental building blocks in the synthesis of RNA nanoparticles. The purpose of this paper is to give an overview of the significance of RNA nanotechnology, a novel idea in the field of nanotechnology.